RxSight, Inc.: cash_and_restricted_cash
| Value | {"amount": 10402000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | RxSight, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/19a5da46-b867-43af-aa8d-78c3897190d9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-053566Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001111485/cash-and-restricted-cash/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/19a5da46-b867-43af-aa8d-78c3897190d9
History
- supersedes {"amount": 10403000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} (evidence 0000950170-24-022073)